CymitQuimica logo

3-Hydroxy thalidomide

CAS:

Ref. 3D-FH46212

5g
303.00€
10g
426.00€
25g
632.00€
50g
958.00€
100g
1,355.00€
3-Hydroxy thalidomide
Biosynth

    Product Information

    Name:3-Hydroxy thalidomide
    Brand:Biosynth
    Description:3-Hydroxy thalidomide is a drug that is used to treat cancer. It is an inhibitor of the ubiquitin-proteasome system and inhibits the growth of cancer cells. It has been shown to inhibit the proliferation of prostate cancer cells in culture, as well as inhibiting the growth of rat liver microsomes. 3-Hydroxy thalidomide has been shown to be suitable for oral administration and it has a long half-life, making it suitable for treatment in patients who cannot tolerate other drugs. 3-Hydroxy thalidomide also inhibits the growth factor basic fibroblast growth factor (bFGF), which may contribute to its anti-cancer effects.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:274.23 g/mol
    Formula:C13H10N2O5
    Purity:Min. 98 Area-%
    Color/Form:Yellow Powder
    InChI:InChI=1S/C13H10N2O5/c16-8-3-1-2-6-10(8)13(20)15(12(6)19)7-4-5-9(17)14-11(7)18/h1-3,7,16H,4-5H2,(H,14,17,18)
    InChI key:InChIKey=XMPJICVFSDYOEG-UHFFFAOYSA-N
    SMILES:O=C1CCC(N2C(=O)c3cccc(O)c3C2=O)C(=O)N1

    Technical inquiry about: 3-Hydroxy thalidomide

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.